Urban Cholera Transmission Hotspots and Their Implications for Reactive Vaccination: Evidence from Bissau City, Guinea Bissau

PLoS Neglected Tropical Diseases

Volumn 6, Issue 11, 2012, Pages

  Azman, Andrew S ^a   Luquero, Francisco J ^b   Rodrigues, Amabelia ^c   Palma, Pedro Pablo ^d   Grais, Rebecca F ^b   Banga, Cunhate Na ^c   Grenfell, Bryan T ^e,f   Lessler, Justin ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b EPICENTRE   (France)

^c Ministry of Health   (Guinea-Bissau)

^d Médicos Sin Fronteras España   (Spain)

^e PRINCETON UNIVERSITY   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ARTICLE; CHOLERA; DISEASE TRANSMISSION; DRUG EFFICACY; EPIDEMIC; GUINEA-BISSAU; HUMAN; IMMUNITY; NONBIOLOGICAL MODEL; SENSITIVITY ANALYSIS; SIMULATION; URBAN AREA; VACCINATION;

CHOLERA; CHOLERA VACCINES; DISEASE TRANSMISSION, INFECTIOUS; GUINEA-BISSAU; HUMANS; MODELS, STATISTICAL; URBAN POPULATION; VACCINATION;

EID: 84870745191     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001901     Document Type: Article

References (29)

1. Sur D, Kanungo S, Sah B, Manna B, Ali M, et al. (2011) Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial. PLoS Neglected Tropical Diseases 5: e1289.
2. Sanchez JL, Vasquez B, Begue RE, Meza R, Castellares G, et al. (1994) Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. The Lancet 344: 1273-1276.
3. Clemens JD, Harris JR, Khan MR, Kay BA, Yunus M, et al. (1986) Field Trial of Oral Cholera Vaccines in Bangladesh. The Lancet 328: 124-127.
4. Anh DD, Lopez AL, Thiem VD, Grahek SL, Duong TN, et al. (2011) Use of Oral Cholera Vaccines in an Outbreak in Vietnam: A Case Control Study. PLoS Neglected Tropical Diseases 5: e1006.
5. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, et al. (2009) Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double blind, placebo-controlled trial. The Lancet 374: 1694-1702.
6. Trach D, Clemens J, Ke N, Thuy H, Son N, (1997) Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. The Lancet 349: 231-235.
7. Legros D, Paquet C, Perea W, Marty I, Mugisha NK, et al. (1999) Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bulletin of the World Health Organization 77: 837-842.
8. Lucas MES, Deen JL, von Seidlein L, Wang XY, Ampuero J, et al. (2005) Effectiveness of mass oral cholera vaccination in Beira, Mozambique. The New England Journal of Medicine 352: 757-767.
9. Calain P, Chaine JP, Johnson E, Hawley ML, O'Leary MJ, et al. (2004) Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22: 2444-2451.
10. World Health Organization (2010) Cholera vaccines: WHO position paper. Weekly Epidemiological Record 85: 117-128.
11. Waldor MK, Hotez PJ, Clemens JD, (2010) A national cholera vaccine stockpile-a new humanitarian and diplomatic resource. The New England Journal of Medicine 363: 2279-2282.
12. Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, et al. (2011) The Case for Reactive Mass Oral Cholera Vaccinations. PLoS Neglected Tropical Diseases 5: e952.
13. Grais RF, Conlan AJK, Ferrari MJ, Djibo A, Le Menach A, et al. (2008) Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. Journal of the Royal Society, Interface/the Royal Society 5: 67-74.
14. World Health Organization Global Task Force on Cholera Control (2008) Cholera Country Profile: Guinea Bissau. Technical report, World Health Organization.
15. Luquero FJ, Banga CN, Remartínez D, Palma PP, Baron E, et al. (2011) Cholera Epidemic in Guinea-Bissau (2008): The Importance of "Place". PLoS ONE 6: e19005.
16. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/. ISBN 3-900051-07-0.
17. Plummer M (2003) JAGS: A Program for Analysis of Bayesian Graphical Models Using Gibbs Sampling. In: Proceedings of the 3rd InternationalWorkshop on Distributed Statistical Computing (DSC 2003). Vienna, Austria.
18. Gelman A, Rubin DB, (1992) Inference from Iterative Simulation Using Multiple Sequences. Statistical Science 7: 457-472.
19. Halloran ME, Longini IM, Struchiner CJ, (2009) Design and Analysis of Vaccine Studies. Springer Verlag.
20. Black RE, Levine MM, Clements ML, Young CR, Svennerholm AM, et al. (1987) Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infection and Immunity 55: 1116-1120.
21. Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, et al. (2009) Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial. Vaccine 27: 6887-6893.
22. Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, et al. (2011) Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine 29: 8285-8292.
23. Dowdy DW, Golub JE, Chaisson RE, Saraceni V, (2012) Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proceedings of the National Academy of Sciences of the United States of America 109: 9557-9562.
24. Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, et al. (2012) Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Medicine 9: e1001165.
25. Alam MM, Riyadh MA, Fatema K, Rahman MA, Akhtar N, et al. (2011) Antigen-Specific Memory B-Cell Responses in Bangladeshi Adults after One- or Two-Dose Oral Killed Cholera Vaccination and Comparison with Responses in Patients with Naturally Acquired Cholera. Clinical and Vaccine Immunology 18: 844-850.
26. Hartley DM, Morris JG, Smith DL, (2006) Hyperinfectivity: A Critical Element in the Ability of V. cholerae to Cause Epidemics? PLoS Medicine 3: e7.
27. Tien JH, Earn DJD, (2010) Multiple Transmission Pathways and Disease Dynamics in aWaterborne Pathogen Model. Bulletin of Mathematical Biology 72: 1506-1533.
28. Grad YH, Miller JC, Lipsitch M, (2012) Cholera modeling: challenges to quantitative analysis and predicting the impact of interventions. Epidemiology 23: 523-530.
29. Aaby P (1997) Bandim: an unplanned longitudinal study. In: Das Gupta M, Aaby P, Garenne M, editors, Prospective community studies in developing countries, Oxford University Press, USA. p. 350.